The LLS Blog
Read about survivors, research, fundraising and advocacy.
Take Part in the Raise Hope, End Cancer Fundraiser with Walgreens
Walgreens, The Leukemia & Lymphoma Society (LLS), and Susan G. Komen (Komen) are collaborating to raise funds to enable new research in breast and blood cancers and expand access, treatment, and support services for those living with these diseases. In 2019, Walgreens pledged to contribute more than $25 million to LLS and Komen collectively over the next five years to improve the health and well-being of people living with cancer nationwide. But we can’t do this alone.
Practicing Self-Advocacy During My PTCL Journey
The LLS Blog invites Aaron, who was diagnosed with peripheral T-cell lymphoma (PTCL), to share his reflections on becoming a self-advocate throughout his cancer experience. Read his powerful first-hand account
Precision Medicine and Combination Therapies #ASH20
The more we learn more about the underlying mutations that drive cancer the better we get at more precisely hitting those targets with specialized, less toxic treatments. We now understand that a one-size-fits all approach to treating cancer is ineffective for many patients. As The 62nd American Society of Hematology (ASH) annual Meeting ends, let’s take a look at results from studies of targeted therapies that work by interfering with the altered genes that cause cancer cells to grow and spread. Much of the work stems from research supported by LLS.
Immunotherapies on a Roll at #ASH20
More than three years after the first chimeric antigen receptor (CAR) T-cell therapy achieved U.S. Food and Drug Administration (FDA) approval, the revolutionary approach that has upended blood cancer treatment continues to generate excitement.
Two Prominent Themes of 2020 Make an Appearance at #ASH20: Covid-19 and Racial Disparities
With the COVID-19 pandemic driving yet another science conference to the virtual world, it is fitting that the 62nd ASH Annual Meeting and Exposition officially kicked off today with a virtual fireside chat via live stream featuring none other than Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, and a member of the administration’s coronavirus task force.